Commonwealth Equity Services, LLC Gamida Cell Ltd. Transaction History

Commonwealth Equity Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$0.04 - $0.46 $168 - $1,932	-4,200 Reduced 2.85%	143,100 $5,000
Q4 2023 Feb 06, 2024	BUY	$0.25 - $1.02 $28,925 - $118,014	115,700 Added 366.14%	147,300 $61,000
Q2 2023 Aug 10, 2023	BUY	$0.73 - $2.37 $23,068 - $74,892	31,600 New	31,600 $61,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.